The Reditest Panel-Dip Substance Abuse Screening Device rapidly screens for a broad range of illicit and prescription drugs.
Devices are easy to use and feature a wide range of configurations for a fully customized test program. Panel-Dip devices are available in single and multi-drug configurations.
1. Drugs of abuse: Amphetamine (AMP1000 or AMP300), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC150 or COC300), Marijuana (THC), Ecstasy (MDMA) Methadone (MTD), Methamphetamine (mAMP1000 or mAMP500), Opiates (OPI300 or OPI2000), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX), and Tricyclic Antidepressants (TCA).
For professional in-vitro diagnostic use only.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result.
Gas chromatography-mass spectrometry (GC/MS) is the preferred confirmatory methods.
A Leader in Toxicology
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Abbott - A Global Leader in Toxicology.
Alere Toxicology is now Abbott Toxicology